Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China · Delayed Price · Currency is CNY 4.140
+0.030 (0.73%)
Apr 29, 2026, 3:04 PM CST
SHE:300194 Revenue
Fuan Pharmaceutical (Group) had revenue of 407.49M CNY in the quarter ending March 31, 2026, a decrease of -12.87%. This brings the company's revenue in the last twelve months to 1.68B, down -18.13% year-over-year. In the year 2025, Fuan Pharmaceutical (Group) had annual revenue of 1.74B, down -27.31%.
Revenue (ttm)
1.68B
Revenue Growth
-18.13%
P/S Ratio
2.94
Revenue / Employee
494.72K
Employees
3,392
Market Cap
4.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.74B | -653.18M | -27.31% |
| Dec 31, 2024 | 2.39B | -256.28M | -9.68% |
| Dec 31, 2023 | 2.65B | 226.01M | 9.33% |
| Jan 1, 2023 | 2.42B | -31.40M | -1.28% |
| Jan 1, 2022 | 2.45B | 84.80M | 3.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Jianmin Pharmaceutical Group | 3.35B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.20B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Bide Pharmatech | 1.32B |
| Teyi Pharmaceutical Group Co.,Ltd | 924.53M |
| Nanjing Hicin Pharmaceutical | 688.74M |